Healthcare
Executive orders related to healthcare policy, public health, and medical research.
25 executive ordersAddressing Addiction Through the Great American Recovery Initiative
This executive order establishes the White House Great American Recovery Initiative to coordinate a federal government response to addiction and substance use disorder. The initiative, co-chaired by the Secretary of Health and Human Services and a Senior Advisor for Addiction Recovery, will work to increase treatment access, raise awareness, integrate addiction services across federal agencies, and collaborate with states, communities, and the private sector.
Increasing Medical Marijuana and Cannabidiol Research
This executive order directs federal agencies to increase medical marijuana and cannabidiol (CBD) research and expand the research infrastructure. It references a 2023 FDA review supporting marijuana's medical use for pain, nausea, and anorexia, and a pending Department of Justice proposal to reschedule marijuana from Schedule I to Schedule III of the Controlled Substances Act.
Fostering the Future for American Children and Families
This executive order directs the federal government to modernize the foster care system through improved data collection, technology adoption, and support for youth aging out of care. It also establishes initiatives to increase foster and adoptive parent recruitment, particularly from faith-based communities, and creates resources for former foster youth seeking education and employment opportunities.
Unlocking Cures for Pediatric Cancer With Artificial Intelligence
This executive order directs federal agencies to leverage artificial intelligence to accelerate research and treatment development for pediatric cancer. It establishes a coordinated effort across the Make America Healthy Again Commission, Department of Health and Human Services, and other agencies to expand the existing Childhood Cancer Data Initiative, improve data infrastructure, increase research funding, and enable private sector participation in AI-driven pediatric cancer solutions.
Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
This executive order directs the Department of Health and Human Services to establish and fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with a 6-month supply of active pharmaceutical ingredients (APIs) for approximately 26 critical medicines. The order aims to reduce U.S. dependence on foreign sources for essential medicine components and domestic pharmaceutical supply chain resilience.
President's Council on Sports, Fitness, and Nutrition, and the Reestablishment of the Presidential Fitness Test
This executive order reestablishes the President's Council on Sports, Fitness, and Nutrition and reinstates the Presidential Fitness Test as a national assessment tool. The order aims to address declining health and fitness rates in America, particularly among youth, by promoting participation in youth sports, physical activity, and good nutrition across all sectors of society.
Ending Crime and Disorder on America's Streets
This executive order directs federal agencies to prioritize civil commitment of homeless individuals with mental illness or substance use disorders, encourage states to enforce anti-vagrancy laws, and redirect federal grants and resources toward institutional treatment rather than community-based harm reduction programs.
Restoring Gold Standard Science
This executive order directs federal agencies to adopt scientific integrity standards emphasizing reproducibility, transparency, and objective use of evidence in federally funded research and policy decisions. It specifically mandates that agencies avoid misleading representations of scientific data, acknowledge uncertainties and scenario assumptions, and discontinue incorporating diversity, equity, and inclusion considerations into science planning and communication.
Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients
This executive order directs the federal government to implement most-favored-nation (MFN) pricing for prescription drugs, requiring American patients to pay prices no higher than those charged in other developed nations. It establishes a 30-day timeline for HHS to communicate MFN price targets to pharmaceutical manufacturers and outlines escalating enforcement actions if manufacturers do not comply.
Keeping Promises to Veterans and Establishing a National Center for Warrior Independence
This executive order directs the Department of Veterans Affairs to establish a National Center for Warrior Independence at the West Los Angeles VA campus to provide housing, treatment, and services for homeless veterans, while also mandating increased accountability measures and expanded care options within the VA system.
Improving the Safety and Security of Biological Research
This executive order establishes stricter oversight and safety protocols for biological research funded by the U.S. federal government. It immediately halts federal funding for gain-of-function research conducted in foreign countries with inadequate oversight, suspends such domestic research pending new policy review, and requires updated frameworks for dual-use research oversight and synthetic nucleic acid screening within 90-120 days.
Regulatory Relief To Promote Domestic Production of Critical Medicines
This executive order directs the Food and Drug Administration to streamline regulatory requirements for domestic pharmaceutical manufacturing to reduce construction timelines and eliminate barriers to producing medicines and critical inputs in the United States. The order aims to accelerate FDA review processes, modernize inspection protocols, and increase oversight of foreign manufacturing facilities.